Company News

European Society for Medical Oncology President joins Imugene Recipharm welcomes CFO Exscientia appoints Georgy Egorov as Chief Financial Officer Rewind Therapeutics appoints CEO Pharma executive joins Healx to drive integration of AI Tekni-Plex names new Asia Sales Director CluePoints strengthens team with two appointments Elligo’s growth supported by new executive leadership Novoheart recruits Chief R&D Officer Oculis appoints chairman to its scientific advisory board BVM appoints Engineering Manager as sustained growth continues Qlucore announces changes to board of directors Spin Transfer Technologies appoints chairman to board of directors Abingworth appoints Brian Gallagher as Partner Geneticist Eleftheria Zeggini leaves Cambridge to join Helmholtz Munich Domainex appoints new CEO

Trending Articles

  1. Alfa Laval appoints new managing director to drive strategic growth Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
  2. How strong leadership transforms regulatory and operational challenges Why SLTs fail on the PQS/QMS: The leadership gap undermining quality
  3. Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics
  4. Kindeva appoints Brok Weichbrodt as Chief Transformation Officer to accelerate growth strategy and commercial excellence Kindeva, a global drug delivery Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Brok Weichbrodt as Chief Transformation Officer to strengthen operational excellence, scale execution, and accelerate growth as the company enters the next phase of its value creation plan
  5. Medicines Discovery Catapult selects prominent UK life sciences leader, Professor Sir Mike Ferguson, as its incoming Chair of the Board MDC welcomes new Chair from January 2027 to drive impact as next-generation technologies and collaborations reshape drug discovery

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all